413 related articles for article (PubMed ID: 12721334)
21. Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys.
Rizzi A; Sukhtankar DD; Ding H; Hayashida K; Ruzza C; Guerrini R; Calò G; Ko MC
Br J Pharmacol; 2015 Jul; 172(14):3661-70. PubMed ID: 25828800
[TBL] [Abstract][Full Text] [Related]
22. Site-specific estrogen and progestin regulation of orphanin FQ/nociceptin and nociceptin opioid receptor mRNA expression in the female rat limbic hypothalamic system.
Sinchak K; Romeo HE; Micevych PE
J Comp Neurol; 2006 May; 496(2):252-68. PubMed ID: 16538678
[TBL] [Abstract][Full Text] [Related]
23. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
[TBL] [Abstract][Full Text] [Related]
24. Roles of nociceptin/orphanin FQ and nociceptin/orphanin FQ peptide receptor in respiratory rhythm generation in the medulla oblongata: an in vitro study.
Takita K; Morimoto Y; Kemmotsu O
Br J Anaesth; 2003 Sep; 91(3):385-9. PubMed ID: 12925479
[TBL] [Abstract][Full Text] [Related]
25. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice.
Nazzaro C; Rizzi A; Salvadori S; Guerrini R; Regoli D; Zeilhofer HU; Calo G
Peptides; 2007 Mar; 28(3):663-9. PubMed ID: 17161885
[TBL] [Abstract][Full Text] [Related]
26. Minocycline enhances the effectiveness of nociceptin/orphanin FQ during neuropathic pain.
Popiolek-Barczyk K; Rojewska E; Jurga AM; Makuch W; Zador F; Borsodi A; Piotrowska A; Przewlocka B; Mika J
Biomed Res Int; 2014; 2014():762930. PubMed ID: 25276817
[TBL] [Abstract][Full Text] [Related]
27. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
Chiou LC; Liao YY; Fan PC; Kuo PH; Wang CH; Riemer C; Prinssen EP
Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
[TBL] [Abstract][Full Text] [Related]
28. Nociceptin/orphanin FQ-NOP receptor system in inflammatory and immune-mediated diseases.
Gavioli EC; de Medeiros IU; Monteiro MC; Calo G; Romão PR
Vitam Horm; 2015; 97():241-66. PubMed ID: 25677775
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex.
Mela F; Marti M; Ulazzi L; Vaccari E; Zucchini S; Trapella C; Salvadori S; Beani L; Bianchi C; Morari M
Eur J Neurosci; 2004 Mar; 19(5):1317-24. PubMed ID: 15016089
[TBL] [Abstract][Full Text] [Related]
30. Role of nociceptin/orphanin FQ in thermoregulation.
Baiula M; Bedini A; Spampinato SM
Neuropeptides; 2015 Apr; 50():51-6. PubMed ID: 25812480
[TBL] [Abstract][Full Text] [Related]
31. Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures.
Bregola G; Zucchini S; Rodi D; Binaschi A; D'Addario C; Landuzzi D; Reinscheid R; Candeletti S; Romualdi P; Simonato M
J Neurosci; 2002 Nov; 22(22):10030-8. PubMed ID: 12427860
[TBL] [Abstract][Full Text] [Related]
32. Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress.
Green MK; Devine DP
Neuropeptides; 2009 Dec; 43(6):507-14. PubMed ID: 19720395
[TBL] [Abstract][Full Text] [Related]
33. Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats.
Rodi D; Polidori C; Bregola G; Zucchini S; Simonato M; Massi M
Brain Res; 2002 Dec; 957(2):354-61. PubMed ID: 12445978
[TBL] [Abstract][Full Text] [Related]
34. Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain.
El Daibani A; Che T
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163856
[TBL] [Abstract][Full Text] [Related]
35. Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia.
Scoto GM; Aricò G; Ronsisvalle S; Parenti C
Peptides; 2007 Jul; 28(7):1441-6. PubMed ID: 17628212
[TBL] [Abstract][Full Text] [Related]
36. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family.
Mogil JS; Pasternak GW
Pharmacol Rev; 2001 Sep; 53(3):381-415. PubMed ID: 11546835
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological activity of small peptides as NOP and opioid receptors' ligands: view on current developments.
Naydenova E; Todorov P; Zamfirova R
Vitam Horm; 2015; 97():123-46. PubMed ID: 25677770
[TBL] [Abstract][Full Text] [Related]
38. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
Delaney G; Dawe KL; Hogan R; Hunjan T; Roper J; Hazell G; Lolait SJ; Fulford AJ
J Neuroendocrinol; 2012 Dec; 24(12):1527-41. PubMed ID: 22835008
[TBL] [Abstract][Full Text] [Related]
39. Quantitative study of [Tyr10]nociceptin/orphanin FQ (1-11) at NOP receptors in rat periaqueductal gray and expressed NOP receptors in HEK293 cells.
Liao YY; Lee CW; Ho IK; Chiou LC
Life Sci; 2012 Feb; 90(7-8):306-12. PubMed ID: 22213115
[TBL] [Abstract][Full Text] [Related]
40. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.
Hashimoto Y; Calo' G; Guerrini R; Smith G; Lambert DG
Eur J Pharmacol; 2002 Aug; 449(1-2):17-22. PubMed ID: 12163101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
